The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of April 2018. This month there are seven guidelines that impact upon primary care.
Five guidelines have all been updated to include warnings that valproate must not be used in pregnancy, and only used in girls and women when there is no alternative and a pregnancy prevention plan is in place. The affected guidelines are:
- the Epilepsies: diagnosis and management clinical guideline
- the Neuropathic pain in adults clinical guideline
- the Bipolar disorder: assessment and management clinical guideline
- the Antenatal and postnatal mental health clinical guideline
- and the Depression in adults clinical guideline
The Lyme Disease guideline has been published. It covers diagnosing and managing Lyme disease. It aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. It does not cover preventing Lyme disease.
The Care and support of people growing older with learning disabilities guideline has been published. It covers care and support for adults with learning disabilities as they grow older. It covers identifying changing needs, planning for the future, and delivering services including health, social care and housing. It aims to support people to access the services they need as they get older.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« Zafirlukast discontinued||Drug Safety Update - April 2018 »|